Universal exercise unit versus rebounding on genu recurvatum in children with cerebral palsy: a comparative randomised controlled trial
Abstract
Introduction
This study aimed to compare the effects of universal exercise unit (UEU) versus rebounding on genu recurvatum (GR) in children with spastic cerebral palsy (CP).
Material and methods
A total of 51 children aged 5–7 years with spastic hemiplegic CP were randomly allocated into three groups: control group (n = 17), and study groups A (n = 17) and group B (n = 17). While all groups received a designed physical therapy programme, the control group additionally received traditional progressive strengthening exercises; group A received the UEU programme, and group B underwent rebound therapy. The primary outcome was GR, while secondary outcomes comprised muscle strength, including the quadriceps and gluteus maximus muscles, balance skills, functional mobility and quality of life, which were evaluated pre- and post-treatment using X-ray, Lafayette manual muscle tester, Pediatric Balance Scale (PBS), Mobility Questionnaire and Pediatric Quality of Life Inventory, respectively.
Results
All groups showed significant post-treatment improvements in all measured outcomes (p < 0.001). Post-treatment comparisons of the outcome measures among the three groups demonstrated a significant enhancement in favour of groups A and B compared with the control group. Post-treatment comparison between groups A and B revealed no significant difference across most measured variables, except for PBS scores, which was significantly improved in favour of group B (p = 0.01).
Conclusions
Both UEU and rebound therapy may be incorporated into the rehabilitation protocol of children with spastic hemiplegic CP to manage GR, while rebound therapy demonstrated an additional statistically significant advantage over UEU, specifically for balance.
© 2026 Józef Piłsudski University of Physical Education in Warsaw
This work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.